Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 Expression in Patients with Non-Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis.

Aghajani, Marra; Graham, Susannah; McCafferty, Charles; Shaheed, Christina Abdel; Roberts, Tara; DeSouza, Paul; Yang, Tao; Niles, Navin

Aghajani, Marra; Graham, Susannah; McCafferty, Charles; Shaheed, Christina Abdel; Roberts, Tara; DeSouza, Paul; Yang, Tao; Niles, Navin.

Affiliation

Aghajani M; 1 Department of Medical Oncology, Ingham Institute for Applied Medical Research , Liverpool, Australia .
Graham S; 2 School of Medicine, Western Sydney University , Campbelltown, Australia .
McCafferty C; 1 Department of Medical Oncology, Ingham Institute for Applied Medical Research , Liverpool, Australia .
Shaheed CA; 2 School of Medicine, Western Sydney University , Campbelltown, Australia .
Roberts T; 3 Department of Head and Neck Surgery, Liverpool Hospital , Liverpool, Australia .
DeSouza P; 2 School of Medicine, Western Sydney University , Campbelltown, Australia .
Yang T; 4 Sydney School of Public Health, University of Sydney , Sydney, Australia .
Niles N; 1 Department of Medical Oncology, Ingham Institute for Applied Medical Research , Liverpool, Australia .

Thyroid ; 28(3): 349-361, 2018 03.

Article in En | MEDLINE | ID: mdl-29455638

Subject(s)
Key words

meta-analysis; prognostic significance; programmed cell death ligand 1; survival; thyroid cancer

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / B7-H1 Antigen / Neoplasm Recurrence, Local Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Thyroid Journal subject: ENDOCRINOLOGIA Year: 2018 Document type: Article Affiliation country: Australia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google